News Sep 19, 2024
Presenter Profile Reveal, Meeting Your CDMO Experts In Booth 5C17
Join us at booth 5C17 for two exclusive presentation sessions aimed at enhancing collaboration with industry professionals. Discover insights and innovations on October.
News Sep 13, 2024
Keep hope alive! We invite you to stay tuned to DMD
From September 6 to 7 2024, the Porton Wecare Program accompanied the families of four Chongqing DMD patients to Shanghai to participate in the 13th China Rare Disease Summit 2024.The summit, co-sponsored by the Chinese Organization for Rare Disorders (CORD) and Xinhua Hospital affiliated with Shanghai Jiaotong University School of Medicine, was held from September 6 to 8, 2024.
News Sep 09, 2024
Join Porton and Industry Elites at Pharma Crystallization Summit 2024!
The Full Agenda for the PCS 2024 is Now Available.
News Aug 27, 2024
Connect with Porton at CPhI Europe 2024 @ Booth 5C17
Early bird registration will close on September 5th, 2024
News Aug 13, 2024
The 5th Pharma Crystallization Summit is coming this September!
Early bird registration will close on September 5th, 2024
News Jul 19, 2024
Porton Passed FDA cGMP Inspection with No Action Indicated（NAI）
STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS
NewslettersJul 07, 2024
Porton Newsletter | Q2 2024 Recap
Porton Pharma Solutions Embark on The Next Frontier in Mengeš, Slovenia. Announcement of New GMP HPAPI Lab and Integrated DS-DP Facilities at Porton J-STAR. Porton can provide one-stop CDMO services from PCC to IND and GMP clinical supply of ADC drugs for global pharmaceutical companies.
News Jul 05, 2024
Technology-Driven | Porton's Crystallization Team and Genentech Jointly Published Breakthrough Results in 《Pharmaceutical Research》
STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS
News Jun 29, 2024
Porton Experts Invited to Participate in the University of Perugia Master PRO-API Program, Aiding in the Training of Green Process Chemistry Professionals
STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS
